Global Leadership PARI is a long-standing global leader in respiratory therapy with a broad international network, indicating strong potential for channel partnerships, distributors, and OEM collaboration across regions with established trust among doctors, pharmacists, and patients.

CF Nebulizers As the global market leader in nebuliser devices for cystic fibrosis, PARI presents a strategic opportunity to cross-sell complementary devices, saline solutions, and upgraded inhalation solutions to CF care programs and specialty clinics.

Integrated Care PARI offers a comprehensive care portfolio spanning diagnosis, treatment, and monitoring. This opens sales opportunities for end-to-end respiratory care solutions, telemonitoring add-ons, and workflow integrations for hospitals and clinics.

Midmarket Growth With an employee base of 201-500 and revenue in the targeted mid-market range, PARI is a suitable partner for mid-size hospitals and regional distributors seeking scalable, reliable respiratory therapy technology and after-sales services.

Industry Synergy Leverage PARI’s ongoing R&D through PARI Pharma and eFlow technology to position co-development of new inhalation therapies, consumables, and service offerings, aligning with buyers looking for innovative, value-added solutions.